Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer

NCT01167530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Locally Advanced Disease

Interventions

DRUG: Everolimus

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]